2-amino-4,5-bis(4-methoxyphenyl)-3-furonitrile, 250mg

tert-Butyl (3-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)amino)propyl)carbamate, 250mg

3-Pyrrol-1-yl-benzoic acid, 95.0%, 10g

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-chloro-2-fluorophenyl)propanoic acid, 97%, 5g

4-Methyl-2-(3,4-dichlorophenyl)thiazole-5-carboxylic acid, 95+%, 5g

(S)-2-Amino-3-methyl-butyric acid methyl ester, 1g

1-(3-chlorophenyl)-3-hydroxybut-2-en-1-one, 95%, 500mg

1H-INDAZOLE-4-CARBOXYLIC ACID, 5-BROMO-6-FLUORO-, METHYL ESTER, 95%, 100mg

Vanillylamine hydrochloride, 98.0%, 10g

N-Methyl-O-(10H-phenothiazine-10-carbonyl)hydroxylamine hydrochloride, 95%, 1g

Cobre en polvo, ROTI®METIC 99,999% (5N), 50 g, envase de vidrio

2'-Deoxycytidine 5'-Monophosphate Hydrate>98.0%(HPLC)(T)100mg

4-(2-Aminopyrimidin-5-yl)benzoic acid, 97.0%, 1g